Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : Lagging Pharmacies Court the Chronically Ill -- -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/06/2019 | 02:48am EDT

Both companies say they will comply with health-privacy laws and won't share data with the retail side of the business.

CVS says its existing capital budgets will cover costs of reinventing stores nationwide. A Walgreens spokesman said investments would be made "in a financially disciplined manner," declining to further quantify.

Unlike CVS, which stopped selling tobacco products in 2014, Walgreens has continued to sell cigarettes in most of its stores, drawing criticism from federal regulators, lawmakers as well as activists who say that tobacco products don't belong in a health store. Mr. Pessina says the chain is testing some tobacco-free stores and is encouraging employees in others to offer aids to quit smoking to customers buying cigarettes.

One recent weekday afternoon, Mr. Pessina, the company's CEO, walked through a store near the company's Deerfield, Ill., headquarters. In an area called the "health corner" were signs for optical, lab, hearing and pharmacy services. As Mr. Pessina quizzed the in-store optometrist about the number of visitors he was getting, a customer shuffled by pushing a shopping cart with a case of Bud Light. Across the store, a woman had her blood pressure checked.

Mr. Pessina said he's convinced moving away from traditional retail is the only way forward. "We are also a retailer," he said. "But we are above all a pharmacy."

Write to Aisha Al-Muslim at aisha.al-muslim@wsj.com and Sharon Terlep at sharon.terlep@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 0.53% 53.07 Delayed Quote.-19.43%
WALGREENS BOOTS ALLIANCE 0.31% 51.77 Delayed Quote.-24.47%
This article is part of a news chaine.
Article 2 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
05/21CVS HEALTH : To Host 2019 Investor Day For The Investment Community
PR
05/17CVS HEALTH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/15NEWS HIGHLIGHTS : Top Company News of the Day
DJ
05/15CVS HEALTH : to Require Third-Party Testing of Vitamins, Supplements
DJ
05/15CVS PHARMACY : Launches 'Tested to Be Trusted' Program for Vitamins and Suppleme..
PR
05/09CVS PHARMACY : Completes Rollout of Time Delay Safes in All of Its Minnesota Pha..
PR
05/06PREMIER : to Exit Specialty Pharmacy Operations in Deal With CVS Unit
DJ
05/06EXCLUSIVE : Hedge funds target Centene, may oppose WellCare deal - sources
RE
05/02CVS HEALTH : to Close 46 Pharmacy Locations - Update
DJ
05/02CVS HEALTH : to Close 46 Pharmacy Locations
DJ
More news
Financials ($)
Sales 2019 252 B
EBIT 2019 14 375 M
Net income 2019 6 545 M
Debt 2019 64 157 M
Yield 2019 3,76%
P/E ratio 2019 10,51
P/E ratio 2020 9,33
EV / Sales 2019 0,53x
EV / Sales 2020 0,49x
Capitalization 68 579 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 68,5 $
Spread / Average Target 30%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors